RDF/XML JSON-LD N3/Turtle RDF/JSON

Melguizo Alonso, Consolación Author

Open Access

Preventive effects of Brassicaceae family for colon cancer prevention: A focus on in vitro studies

  • Peña M.
  • Guzmán A.
  • Martínez R.
  • Mesas C.
  • Prados J.
  • Porres J.M.
  • Melguizo C.
... View more Collapse

BIOMEDICINE and PHARMACOTHERAPY - 1/7/2022

10.1016/j.biopha.2022.113145

Cite count: 7 (Web of Science) 1 (Scopus)
  • JCR Quartile: Q1 (2022)
  • JCR Impact Factor: 7.5 (2022)
  • Category normalized Impact: 2.369 (2022)
  • CiteScore: 11.6 (2021)
  • SJR: 1.194 (2021
  • SNIP: 1.517 (2021
  • JCR 5-year Impact Factor: 6.8
  • JCR Categories: PHARMACOLOGY & PHARMACY
Open Access

Colon cancer therapy with calcium phosphate nanoparticles loading bioactive compounds from Euphorbia lathyris: In vitro and in vivo assay

  • Mesas C.
  • Garcés V.
  • Martínez R.
  • Ortiz R.
  • Doello K.
  • Dominguez-Vera J.M.
  • Bermúdez F.
  • Porres J.M.
  • López-Jurado M.
  • Melguizo C.
  • Delgado-López J.M.
  • Prados J.
... View more Collapse

BIOMEDICINE and PHARMACOTHERAPY - 1/11/2022

10.1016/j.biopha.2022.113723

Cite count: 7 (Web of Science) 1 (Scopus)
  • JCR Quartile: Q1 (2022)
  • JCR Impact Factor: 7.5 (2022)
  • Category normalized Impact: 0.948 (2022)
  • CiteScore: 11.6 (2021)
  • SJR: 1.194 (2021
  • SNIP: 1.517 (2021
  • JCR 5-year Impact Factor: 6.8
  • JCR Categories: PHARMACOLOGY & PHARMACY
Open Access

PARP1 inhibition by Olaparib reduces the lethality of pancreatic cancer cells and increases their sensitivity to Gemcitabine

  • Quiñonero F.
  • Mesas C.
  • Muñoz-Gámez J.A.
  • Jiménez-Luna C.
  • Perazzoli G.
  • Prados J.
  • Melguizo C.
  • Ortiz R.
... View more Collapse

BIOMEDICINE and PHARMACOTHERAPY - 1/11/2022

10.1016/j.biopha.2022.113669

Cite count: 4 (Web of Science)
  • JCR Impact Factor: 7.5 (2022)
  • CiteScore: 11.6 (2021)
  • SJR: 1.194 (2021
  • SNIP: 1.517 (2021
  • JCR 5-year Impact Factor: 6.8
  • JCR Categories: PHARMACOLOGY & PHARMACY
Open Access

Gef gene therapy enhances the therapeutic efficacy of cytotoxics in colon cancer cells

  • Ortiz R.
  • Prados J.
  • Melguizo C.
  • Rama A.R.
  • Álvarez P.J.
  • Rodríguez-Serrano F.
  • Caba O.
  • Boulaiz H.
  • Aranega A.
... View more Collapse

BIOMEDICINE and PHARMACOTHERAPY - 1/10/2012

10.1016/j.biopha.2012.05.004

Cite count: 6 (Web of Science) 5 (Scopus)
  • SJR Quartile: Q2
  • JCR Impact Factor: 2.068 (2012)
  • CiteScore: 9.3 (2020)
  • SJR: 0.713 (2012
  • SNIP: 0.923 (2012
  • JCR 5-year Impact Factor: 2.231
  • JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
  • SJR Categories: Medicine (miscellaneous) (Q2); Pharmacology (Q2)
Open Access

Paclitaxel antitumor effect improvement in lung cancer and prevention of the painful neuropathy using large pegylated cationic liposomes

  • Jiménez-López J.
  • Bravo-Caparrós I.
  • Cabeza L.
  • Nieto F.R.
  • Ortiz R.
  • Perazzoli G.
  • Fernández-Segura E.
  • Cañizares F.J.
  • Baeyens J.M.
  • Melguizo C.
  • Prados J.
... View more Collapse

BIOMEDICINE and PHARMACOTHERAPY - 1/1/2021

10.1016/j.biopha.2020.111059

Cite count: 28 (Web of Science) 10 (Scopus)
  • JCR Impact Factor: 7.419 (2021)
  • CiteScore: 9.3 (2020)
  • SJR: 1.323 (2020
  • SNIP: 1.443 (2020
  • JCR 5-year Impact Factor: 6.581
  • JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
Open Access

In vivo antitumor activity of Euphorbia lathyris ethanol extract in colon cancer models

  • Mesas C.
  • Martínez R.
  • Doello K.
  • Ortiz R.
  • López-Jurado M.
  • Bermúdez F.
  • Quiñonero F.
  • Prados J.
  • Porres J.M.
  • Melguizo C.
... View more Collapse

BIOMEDICINE and PHARMACOTHERAPY - 1/5/2022

10.1016/j.biopha.2022.112883

Cite count: 7 (Web of Science) 3 (Scopus)
  • JCR Quartile: Q1 (2022)
  • JCR Impact Factor: 7.5 (2022)
  • Category normalized Impact: 1.895 (2022)
  • CiteScore: 11.6 (2021)
  • SJR: 1.194 (2021
  • SNIP: 1.517 (2021
  • JCR 5-year Impact Factor: 6.8
  • JCR Categories: PHARMACOLOGY & PHARMACY
Open Access

Antitumor activity of bengamide ii in a panel of human and murine tumor cell lines: In vitro and in vivo determination of effectiveness against lung cancer

  • Alba Ortigosa-Palomo
  • Cristina Porras-Alcalá
  • Francisco Quiñonero
  • Federico Moya-Utrera
  • Raúl Ortiz
  • Juan M. López-Romero
  • Consolación Melguizo
  • Francisco Sarabia
  • Jose Prados
... View more Collapse

Biomedicine & Pharmacotherapy - 1/12/2023

10.1016/j.biopha.2023.115789

Cite count: 1 (Web of Science)
  • CiteScore: 12.6 (2022)
  • SJR: 1.366 (2022
  • SNIP: 1.576 (2022
Open Access

Antioxidant and antiproliferative potential of ethanolic extracts from Moringa oleifera, Tropaeolum tuberosum and Annona cherimola in colorrectal cancer cells.

  • Fuel M.
  • Mesas C.
  • Martínez R.
  • Ortiz R.
  • Quiñonero F.
  • Prados J.
  • Porres J.M.
  • Melguizo C.
... View more Collapse

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 30/09/2021

10.1016/j.biopha.2021.112248

Cite count: 10 (Web of Science) 1 (Scopus)
  • JCR Quartile: Q1 (2021)
  • JCR Impact Factor: 7.419 (2022)
  • Category normalized Impact: 1.373 (2021)
  • CiteScore: 9.3 (2020)
  • SJR: 1.323 (2020
  • SNIP: 1.443 (2020
  • JCR 5-year Impact Factor: 6.581
  • JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
Open Access

Regulatory Systems in Bone Marrow for Hematopoietic Stem/Progenitor Cells Mobilization and Homing

  • Alvarez, P.
  • Carrillo, E.
  • Velez, C.
  • Hita-Contreras, F.
  • Martinez-Amat, A.
  • Rodriguez-Serrano, F.
  • Boulaiz, H.
  • Ortiz, R.
  • Melguizo, C.
  • Prados, J.
  • Aranega, A.
... View more Collapse

Biomed Research International - 19/7/2013

10.1155/2013/312656

Cite count: 34 (Web of Science) 30 (Scopus)
  • SJR Quartile: Q1
  • CiteScore: 4.1 (2020)
  • SJR: 1.175 (2013
  • SNIP: 1.009 (2013
  • JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
  • SJR Categories: Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Immunology and Microbiology (miscellaneous) (Q2)

Differentiation of human mesenchymal stem cells towards neuronal lineage: Clinical trials in nervous system disorders

  • Hernández R.
  • Jiménez-Luna C.
  • Perales-Adán J.
  • Perazzoli G.
  • Melguizo C.
  • Prados J.

Biomolecules and Therapeutics - 1/1/2020

10.4062/biomolther.2019.065

Cite count: 70 (Web of Science) 30 (Scopus)
  • JCR Impact Factor: 4.634 (2020)
  • CiteScore: 6.5 (2020)
  • SJR: 0.977 (2020
  • SNIP: 1.011 (2020
  • JCR 5-year Impact Factor: 3.815
  • JCR Categories: PHARMACOLOGY & PHARMACY

The story of a doctoral thesis: GEF, a new gene with applications in anti-tumor gene therapy

  • Boulaiz, H
  • Prados, J
  • Melguizo, C
  • Marchal, JA
  • Carrillo, E
  • Velez, C
  • Fernandez, JE
  • Alvarez, L
  • Caba, O
  • Aranega, A
... View more Collapse

CELLULAR AND MOLECULAR BIOLOGY - 06/2003

  • JCR Quartile: Q4 (2003)
  • SJR Quartile: Q1
  • JCR Impact Factor: 1.153 (2022)
  • SJR Categories: Medicine (miscellaneous) (Q1)

Role of cancer stem cells of breast, colon, and melanoma tumors in the response to antitumor therapy

  • Marchal J.
  • García M.
  • Boulaiz H.
  • Perán M.
  • Álvarez P.
  • Prados J.
  • Melguizo C.
  • Aránega A.
... View more Collapse

Stem Cells and Cancer Stem Cells, Volume 3: Stem Cells and Cancer Stem Cells, Therapeutic Applications in Disease and Injury: Volume 3 - 1/1/2012

10.1007/978-94-007-2415-0_15

Cite count:

This author has no conferences.

This author has no patents.

Open Access

Downregulated microRNAs in the colorectal cancer: Diagnostic and therapeutic perspectives

  • Hernández R.
  • Sánchez-Jiménez E.
  • Melguizo C.
  • Prados J.
  • Rama A.R.

BMB Reports - 1/1/2018

10.5483/bmbrep.2018.51.11.116

Cite count: 19 (Web of Science) 12 (Scopus)
  • SJR Quartile: Q1
  • JCR Impact Factor: 2.966 (2018)
  • CiteScore: 6 (2020)
  • SJR: 1.082 (2018
  • SNIP: 0.952 (2018
  • JCR 5-year Impact Factor: 2.838
  • JCR Categories: BIOCHEMISTRY & MOLECULAR BIOLOGY
  • SJR Categories: Medicine (miscellaneous) (Q1); Biochemistry (Q2); Molecular Biology (Q2)

Correction: Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer (Cancer Gene Therapy, (2019), 10.1038/s41417-019-0137-3)

  • Ballesteros A.
  • Hernández R.
  • Perazzoli G.
  • Cabeza L.
  • Melguizo C.
  • Vélez C.
  • Prados J.
... View more Collapse

CANCER GENE THERAPY - 1/1/2020

10.1038/s41417-020-0166-y

Cite count:
  • JCR Impact Factor: 5.987 (2020)
  • CiteScore: 8.1 (2020)
  • SJR: 1.535 (2020
  • SNIP: 1.113 (2020
  • JCR 5-year Impact Factor: 5.358
  • JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
Open Access

Synthesis, solubility and antitumor activity of maslinic acid derivatives

  • Fuentes-Rios, D.
  • Cepero, A.
  • Garcia-Castro, M.
  • Contreras-Caceres, R.
  • Lopez-Romero, J. M.
  • Luque, C.
  • Cabeza, L.
  • Melguizo, C.
  • Prados, J.
... View more Collapse

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS - 4/2022

10.1016/j.ejmcr.2022.100032

Cite count: 4 (Web of Science)

Nanomedicine and Hyperthermia for the Treatment of Gastrointestinal Cancer: A Systematic Review

  • Lidia Gago
  • Francisco Quiñonero
  • Gloria Perazzoli
  • Consolacion Melguizo
  • Jose Prados
  • Raul Ortiz
  • Laura Cabeza
... View more Collapse

Pharmaceutics - 13/06/2023

10.3390/pharmaceutics15071958

Cite count: 2 (Web of Science) 1 (Scopus)

Scopus: 27

Web of Science: 30

Scopus: 78

Web of Science: 90

Last data update: 5/18/24 7:53 AM
Next scheduled update: 5/25/24 3:00 AM